Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Generic Cardio Drugs Equal Brands
Dec 02, 2008 06:29 PM
- Health Cost Containment Index: Expanding Into India, Impax Labs Set to Re-List
Nov 27, 2008 12:55 AM
- Stock Picks For Healthy Returns
Nov 25, 2008 10:19 AM
- Teva Beats On Profits: A Biogeneric Boon In '09?
Nov 06, 2008 09:56 AM
- An Overview and Analysis of the Global Generic Drug Industry
Aug 16, 2008 01:29 PM
- Momenta Pharma : Stars Could be Finally Aligning for the FDA Approval
Apr 28, 2008 09:34 AM
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006
Mar 07, 2008 10:05 AM
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006
Mar 02, 2008 11:11 PM
- Lovenox Patent Case Back at Federal Circuit; Generic Versions Still Not Yet Approved
Nov 30, 2007 01:15 PM
- Dollar Pressure
Nov 07, 2007 10:28 AM
- Momenta Pharmaceuticals to Present At Upcoming Conferences
Nov 05, 2008 04:31 PM
- Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2008
Nov 03, 2008 08:03 AM
- Momenta Pharmaceuticals to Present At Oppenheimer 19th Annual Healthcare Conference
Oct 29, 2008 04:31 PM
- Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2008 Financial Results
Oct 22, 2008 04:30 PM
- Momenta Pharmaceuticals to Present At the UBS Global Life Science Conference
Sep 16, 2008 04:15 PM
- Momenta Pharmaceuticals to Present At the 3rd Annual Citi Biotech Day
Sep 04, 2008 12:14 PM
- Momenta Pharmaceuticals to Present At the Morgan Stanley Global Healthcare Unplugged Conference
Sep 04, 2008 12:13 PM
- Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection
Jul 29, 2008 01:45 PM
- Momenta Pharmaceuticals Announces Results from M118 Drug-Drug Interaction Study with Aspirin and Clopidogrel
Jul 28, 2008 01:30 PM
- Momenta Pharmaceuticals Announces Data Presentations On M118 At Upcoming IXth World Conference On Clinical Pharmacology and Therapeutics Meeting
Jul 25, 2008 02:19 PM
- Form 4 Shea Richard P For: Nov 19 (10K)
Nov 21, 2008 02:25 PM
- Form 4 SULAT JAMES R For: Sep 12 (10K)
Sep 15, 2008 04:25 PM
- Form 4 Crane Alan L For: Aug 25 (10K)
Aug 28, 2008 06:44 PM
- Form 4 MOMENTA PHARMACEUTICALS For: Aug 22 Filed by: Shapiro Bennett M (10K)
Aug 26, 2008 06:00 PM
- Form 4 MOMENTA PHARMACEUTICALS For: Aug 15 Filed by: Crane Alan L (10K)
Aug 20, 2008 06:42 PM
- Form 4 MOMENTA PHARMACEUTICALS For: Aug 19 Filed by: Leicher Bruce (10K)
Aug 20, 2008 04:54 PM
- Form 4 MOMENTA PHARMACEUTICALS For: Aug 08 Filed by: LANGER ROBERT (10K)
Aug 11, 2008 05:00 PM
- Form 4 MOMENTA PHARMACEUTICALS For: Aug 06 Filed by: Bishop John E (10K)
Aug 07, 2008 05:50 PM
- Form 3 Leicher Bruce For: Jul 24 (10K)
Jul 25, 2008 04:20 PM
- Form 4 MOMENTA PHARMACEUTICALS For: Jun 16 Filed by: Bishop John E (10K)
Jun 18, 2008 05:23 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
MNTA
|
Compare to S&P
|
| YTD |
16.95 %
|
-0.01 %
|
| 4 Weeks |
-7.84 %
|
9.20 %
|
| 12 Weeks |
-40.23 %
|
-13.77 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -7.14 %
|
|
EPS Growth in Last Year: 15.09 %
|
|
Sales Growth in Last Quarter: 9.85 %
|
|
Sales Growth in Last Quarter: -23.93 %
|
|
|
